Success Metrics

Clinical Success Rate
76.5%

Based on 13 completed trials

Completion Rate
76%(13/17)
Active Trials
5(19%)
Results Posted
85%(11 trials)
Terminated
4(15%)

Phase Distribution

Ph phase_1
8
31%
Ph not_applicable
2
8%
Ph phase_2
13
50%
Ph early_phase_1
1
4%

Phase Distribution

9

Early Stage

13

Mid Stage

0

Late Stage

Phase Distribution24 total trials
Early Phase 1First-in-human
1(4.2%)
Phase 1Safety & dosage
8(33.3%)
Phase 2Efficacy & side effects
13(54.2%)
N/ANon-phased studies
2(8.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

65.0%

13 of 20 finished

Non-Completion Rate

35.0%

7 ended early

Currently Active

5

trials recruiting

Total Trials

26

all time

Status Distribution
Active(6)
Completed(13)
Terminated(7)

Detailed Status

Completed13
Recruiting5
Terminated4
Withdrawn3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
26
Active
5
Success Rate
76.5%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (4.2%)
Phase 18 (33.3%)
Phase 213 (54.2%)
N/A2 (8.3%)

Trials by Status

completed1350%
terminated415%
not_yet_recruiting14%
withdrawn312%
recruiting519%

Recent Activity

Clinical Trials (26)

Showing 20 of 26 trialsScroll for more
NCT04981119

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Recruiting
NCT07428993Phase 2

Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma

Not Yet Recruiting
NCT06414889Phase 1

Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder

Recruiting
NCT07137312

Ex Vivo Expansion (ACT-X)

Recruiting
NCT01526096Phase 1

Stem Cell Transplantation for Patients With Multiple Myeloma

Completed
NCT04548843Phase 1

A First in Human Study to Evaluate the Safety of Infusion of MNV-BM-PLC (Autologous CD34+ Cells Enriched With Placenta Derived Allogeneic Mitochondria) in Patients With Primary Mitochondrial Diseases Associated With Mitochondrial DNA Mutation or Deletion

Withdrawn
NCT03448393Phase 1

CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies

Completed
NCT06709326Not Applicable

APACA-Apheresis/acoustophoresis and Molecular Characterization of Prostate Cancer

Recruiting
NCT06381830Phase 2

Clinical Study of CAR-T Cell Therapy Following ASCT for R/R B-cell Non-Hodgkin's Lymphoma

Recruiting
NCT00051311Phase 2

Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System Cancers

Completed
NCT00651937Phase 2

Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden

Completed
NCT00048100Phase 1

Anti-Leukemic Dendritic Cell Activated Donor Lymphocytes

Terminated
NCT00383071Phase 2

Development of Immune Globulin Treatment for Avian Flu

Terminated
NCT00923741Phase 1

Effect of Talactoferrin in Adults With Non-Small Cell Lung Cancer

Completed
NCT01174082Phase 2

Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant

Terminated
NCT00984165Phase 2

Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation

Terminated
NCT01547806Phase 2

Collection of Transplant Stem Cells for Plasma Cell Myeloma

Completed
NCT02098109Phase 2

Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma

Completed
NCT03189888Not Applicable

Granulocyte-monocyte Apheresis in Ulcerative Colitis

Completed
NCT00733824Phase 1

Intravenous AMD3100 for Collection of Autologous Peripheral Blood Stem Cells in Patients With Lymphoma

Completed

Drug Details

Intervention Type
OTHER
Total Trials
26